Listerine, a leading mouth rinse brand, is proud to announce the UK launch of its new Listerine range in three distinct flavour intensities – extra mild, mild, and intense.
While every patient is unique, clinical recommendations should always be grounded in robust evidence. Supported by more than 75 years of research and more than 100 clinical studies, Listerine with clinically proven essential oils is backed by guidelines and systematic reviews demonstrating its efficacy in managing plaque biofilm when used as an adjunct to mechanical cleaning (Figuero et al, 2020; West et al, 2021; DHSC, 2025).
Maintaining good oral health is fundamental to overall well-being, yet periodontal diseases continue to rise globally (WHO, 2022). While mechanical plaque control remains the cornerstone of oral hygiene, compliance with effective daily routines can be challenging, often impacted by patient preference and experience (DHSC, 2025; Slot et al, 2012; Sälzer et al, 2015). Research reveals that patients are divided in their preference for mouthwash intensity – with some seeking a gentler, mild experience, and others preferring the stronger, refreshing sensation associated with intense formulations (Toonen et al, 2024).
The new flavour intensity range directly responds to this insight, allowing dental professionals to tailor their recommendations to patient preferences without compromising on clinical standards or evidence-based efficacy. This personalised approach aims to improve patient compliance, helping ensure that daily mouthwash use becomes a consistent and effective part of oral hygiene routines.
A wealth of scientific evidence – including systematic reviews, meta-analyses, the European Federation of Periodontology’s (EFP) S3-level stage I–III clinical practice guideline, and the Principles for Oral Health Report – supports the adjunctive use of antiseptic mouth rinses (Figuero et al, 2020; West et al, 2021; DHSC, 2025; Chapple et al, 2024). Among these, essential oil formulations are consistently recognised as some of the most effective agents for reducing plaque and maintaining gingival health (Figuero et al, 2020; Chapple et al, 2024).
Backed by science and trusted by professionals, Listerine continues to champion evidence-based oral care through its Re-Evaluate Rinse initiative – encouraging dental teams to reconsider the value of proven antiseptic mouth rinses as part of comprehensive plaque biofilm management. Evidence-based. Patient-focused.
For more information visit kenvuepro.com.
References
- Figuero E, Roldán S, Serrano J, Escribano M, Martín C, Preshaw PM. Efficacy of adjunctive therapies in patients with gingival inflammation: a systematic review and meta-analysis. J Clin Periodontol 2020; 47: 125-143.
- West N, Chapple I, Claydon N, et al. BSP implementation of European S3-level evidence-based treatment guidelines for stage I–III periodontitis in UK clinical practice. J Dent 2021; 106: 103562.
- Department of Health and Social Care; NHS England. Delivering Better Oral Health: Chapter 5 – periodontal diseases. Updated 10 September 2025. GOV.UK.
- World Health Organization. Draft Global Strategy on Oral Health. Annex 3 to A75/10 Add.1. Geneva: WHO; 2022.
- Slot DE, Wiggelinkhuizen L, Rosema NAM, Van der Weijden GA. The efficacy of manual toothbrushes following a brushing exercise: a systematic review. Int J Dent Hyg 2012; 10: 187-197.
- Sälzer S, Slot DE, Van der Weijden FA, Dörfer CE. Efficacy of inter-dental mechanical plaque control in managing gingivitis – a meta-review. J Clin Periodontol 2015; 42(Suppl 16): S92-S105.
- Toonen LSJ, van Swaaij BWM, Timmerman MF, Van der Weijden GA, Slot DE. User perception of fluoride mouthwashes for daily use: a randomized clinical trial. Int J Dent Hyg 2024; 23(1): 153-163.
- Chapple I, Dommisch H, Eren Kuru B, et al. Principles for Oral Health: A global consensus report on the role of antimicrobial/antiseptic agents in daily oral care. SEPA / Principles for Oral Health Alliance; 2024.
This article is sponsored by Listerine.
